TickerFacts.

enVVeno Medical Corp (NVNO): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$15.57M
Year ended 2025-12-31
2017-12-31: -$4.21M2018-12-31: -$6.37M2019-12-31: -$6.26M2020-12-31: -$7.86M2021-12-31: -$12.22M2022-12-31: -$15.73M2023-12-31: -$18.89M2024-12-31: -$16.88M2025-12-31: -$15.57M-$15.57M
2017-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$15.57Mn/m2026-03-26, From 2025-01-01
2024-12-31-$16.88Mn/m2026-03-26, From 2024-01-01
2023-12-31-$18.89Mn/m2025-02-28, From 2023-01-01
2022-12-31-$15.73Mn/m2024-02-29, From 2022-01-01
2021-12-31-$12.22Mn/m2023-03-02, From 2021-01-01
2020-12-31-$7.86Mn/m2022-03-28, From 2020-01-01
2019-12-31-$6.26Mn/m2021-03-31, From 2019-01-01
2018-12-31-$6.37Mn/m2020-03-18, From 2018-01-01
2017-12-31-$4.21Mn/a2019-03-14, From 2017-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
enVVeno Medical Corp (NVNO)2025-12-31-$15.57Mn/m
KORU Medical Systems, Inc. (KRMD)2025-12-31-$470.1Kn/m
WORK Medical Technology Group LTD (WOK)2025-09-30$4.91Mn/m
Interpace Biosciences, Inc. (IDXG)2025-12-31$5.47M+45.2%
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$17.60Mn/m
Co-Diagnostics, Inc. (CODX)2025-12-31-$29.84Mn/m
TriSalus Life Sciences, Inc. (TLSI)2025-12-31-$18.93Mn/m
Beyond Air, Inc. (XAIR)2026-03-31-$19.17Mn/m
Premier Air Charter Holdings Inc. (PREM)2025-12-31-$1.40Mn/m

Compare NVNO, KRMD, WOK, IDXG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗